93 related articles for article (PubMed ID: 3015811)
1. Alpha-2-adrenoreceptor density on intact platelets and adrenaline-induced platelet aggregation in endurance- and nonendurance-trained subjects.
Lehmann M; Hasler K; Bergdolt E; Keul J
Int J Sports Med; 1986 Jun; 7(3):172-6. PubMed ID: 3015811
[TBL] [Abstract][Full Text] [Related]
2. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
3. [Free and conjugated plasma catecholamines, lactate behavior and oxygen uptake at rest and in staged physical exertion as well as alpha receptor density in intact thrombocytes in trained athletes].
Lehmann M; Jakob E; Spöri U; Bergdolt E; Keul J
Z Kardiol; 1985 Jan; 74(1):32-8. PubMed ID: 2983504
[TBL] [Abstract][Full Text] [Related]
4. Endurance training and human alpha 2-adrenergic receptors on platelets.
Lockette W; McCurdy R; Smith S; Carretero O
Med Sci Sports Exerc; 1987 Feb; 19(1):7-10. PubMed ID: 3029532
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
6. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
Brodde OE; Daul A; O'Hara N; Bock KD
J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
[TBL] [Abstract][Full Text] [Related]
7. [Induced platelet aggregation in patients with coronary heart disease as well as trained and untrained control persons].
Lehmann M; Hasler K; Hasenfuss G; Holubarsch C; Staiger A; Kasper W; Keul J
Z Kardiol; 1985 Oct; 74(10):611-7. PubMed ID: 4072333
[TBL] [Abstract][Full Text] [Related]
8. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1.
Wachtogel YT; Musial J; Jenkin B; Niewiarowski S; Edmunds LH; Colman RW
J Lab Clin Med; 1985 May; 105(5):601-7. PubMed ID: 4039346
[TBL] [Abstract][Full Text] [Related]
9. Human platelet alpha 2-adrenoceptors: relationship between radioligand binding studies and adrenaline-induced aggregation in normal individuals.
Swart SS; Pearson D; Wood JK; Barnett DB
Eur J Pharmacol; 1984 Aug; 103(1-2):25-32. PubMed ID: 6090177
[TBL] [Abstract][Full Text] [Related]
10. Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina.
Mehta J; Mehta P; Ostrowski N
J Lab Clin Med; 1985 Dec; 106(6):661-6. PubMed ID: 2866219
[TBL] [Abstract][Full Text] [Related]
11. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
12. Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.
Hollister AS; FitzGerald GA; Nadeau JH; Robertson D
J Clin Invest; 1983 Oct; 72(4):1498-505. PubMed ID: 6138365
[TBL] [Abstract][Full Text] [Related]
13. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
Corby DG; O'Barr TP
Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
[TBL] [Abstract][Full Text] [Related]
14. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.
O'Hara N; Yokota S; Kouchi Y; Ono H
Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728
[TBL] [Abstract][Full Text] [Related]
15. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
[TBL] [Abstract][Full Text] [Related]
16. Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation.
Baldassarre D; Mores N; Colli S; Pazzucconi F; Sirtori CR; Tremoli E
Clin Pharmacol Ther; 1997 Jun; 61(6):684-91. PubMed ID: 9209252
[TBL] [Abstract][Full Text] [Related]
17. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
18. [Alpha 2-adrenergic receptors and arterial pressure].
Senard JM; Valet P; Galinier M; Tran MA; Galinier F; Boneu B; Montastruc JL
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1139-41. PubMed ID: 2554834
[TBL] [Abstract][Full Text] [Related]
19. Characterization of platelet alpha 2 adrenoceptors and measurement in control and depressed subjects.
Campbell IC; McKernan RM; Checkley SA; Glass IB; Thompson C; Shur E
Psychiatry Res; 1985 Jan; 14(1):17-31. PubMed ID: 2986192
[TBL] [Abstract][Full Text] [Related]
20. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
